DCAT Week is one of the pharmaceutical industry’s leading executive forums, bringing together decision-makers in strategic sourcing, contract development, and global supply partnerships. Farmak International, headquartered in Switzerland, manufactures complex generics and hospital medicines, offering integrated development and EU-GMP-certified production for long-term partnerships. Priority Focus Areas Farmak International’s portfolio strategy is centered around high-barrier and hospital-relevant segments, including: • Complex generics and advanced injectable formats • Anaesthesiology & Intensive Care Medicines • MRI & CT contrast imaging solutions • Long-acting injectables (LAIs), which require specialized manufacturing capabilities As an EU-GMP manufacturer with experience across multiple dosage forms, Farmak International supports pharmaceutical companies, distributors, and institutional buyers across Europe, the Middle East, Asia, and other international markets. The company currently operates in more than 60 countries worldwide. Meet Our Team at DCAT Week Farmak International will be represented in New York by: Viktor Kostiuk – Chief Executive Officer, President of the Board Roberto Asensio – Chief Business Development Officer Iryna Rozhnovska – Senior Business Development Manager Take the opportunity to connect with our team during DCAT Week to explore strategic sourcing opportunities, portfolio expansion, development collaborations, and international supply partnerships. We invite you to discuss potential collaborations with us. Schedule a Meeting To arrange a meeting during DCAT Week 2026, please contact: bd@farmak.ch Further information about Farmak International’s portfolio, manufacturing capabilities, and international presence is available at: www.farmak.ch
